H2020-JTI-IMI2-2018-15-two-stage · AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries
Horizon 2020Horizon 2020€386.7m
Specific Challenge:There are significant scientific challenges to the discovery and development of new agents to treat and prevent AMR infections, including those caused by Gram-positive and Gram-negative bacteria, *Mycobacterium tuberculosis*, and non-tubercular mycobacteria (NTM). Models, approac…
Topics
Country:eu WideEligible:clinical Research ConsortiumEligible:healthcare ProviderEligible:research InstitutionEligible:UniversityFunding Size:unknownOpportunity Kind:project GrantOpportunity Type:grantSource:FTTiming:UnknownDigitalHealthManufacturingEnvironmentSpaceInnovation General
Partner types
clinical_research_consortium, healthcare_provider, research_institution, university
